CD274 and neoplasm: Biomarker analyses revealed high SV burden, JAK1 frameshift mutations and low IFN-γ expression as possible resistance mechanisms to anti-PDL1 in dMMR/MSI-H tumours, providing a rationale for larger studies to validate these findings.